Companion Diagnostics and Predictive Biomarkers for MET-Targeted Therapy in NSCLC
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14092150
Abstract: Simple Summary MET is a receptor tyrosine kinase encoded by the MET proto-oncogene that has a significant role in cancer cell progression. Several drugs targeting MET are under development for the treatment of different cancers,… read more here.
Keywords: met amplification; targeted therapy; treatment; met targeted ... See more keywords